Journal Title：Critical Reviews In Therapeutic Drug Carrier Systems

Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields.

Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.

各種藥物載體系統(tǒng)的治療用途對(duì)許多慢性疾病的治療和潛在治愈具有重大影響，包括癌癥、糖尿病、牛皮癬、帕金森病、阿爾茨海默病、類風(fēng)濕性關(guān)節(jié)炎、艾滋病毒感染、傳染病、哮喘和藥物成癮。這些領(lǐng)域的科學(xué)努力涉及物理、生物、醫(yī)學(xué)、制藥、生物材料和工程等領(lǐng)域。

有關(guān)該領(lǐng)域的文章出現(xiàn)在各種各樣的期刊上。隨著文章數(shù)量的大幅增加和科學(xué)的碎片化趨勢(shì)，跟上文獻(xiàn)的步伐并整理和評(píng)估數(shù)據(jù)的重要性和可靠性變得越來越困難，尤其是在涉及專有考慮的情況下。如果不額外閱讀原始文獻(xiàn)，摘要和非批判性文章通常無法為正確評(píng)估特定領(lǐng)域提供足夠可靠的基礎(chǔ)。本期刊通過發(fā)表權(quán)威、客觀、全面的多學(xué)科批判性評(píng)論論文來彌補(bǔ)這一差距，重點(diǎn)關(guān)注配方和給藥系統(tǒng)。受邀文章和投稿文章均需經(jīng)過同行評(píng)審。

Critical Reviews In Therapeutic Drug Carrier Systems創(chuàng)刊于1984年，由Begell House Inc.出版商出版，收稿方向涵蓋藥學(xué) - 醫(yī)學(xué)全領(lǐng)域，此期刊水平偏中等偏靠后，在所屬細(xì)分領(lǐng)域中專業(yè)影響力一般，過審相對(duì)較易，如果您文章質(zhì)量佳，選擇此期刊，發(fā)表機(jī)率較高。平均審稿速度 12周，或約稿 ，影響因子指數(shù)3，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。